Objective: Combination therapy is needed to treat extensively drug-resistant (XDR) Acinetobacter baumannii infection. Colistin (Col) in combination with another drug is usually used for that purpose. The aim of this study was to determine the activity of antimicrobial combinations against XDR A. baumannii using both standard checkerboard (CB) method and E-test. E-test was also evaluated for application in a diagnostic bacteriology laboratory by comparing its efficacy with that of CB method. Methods: Eighty clinical isolates of XDR A. baumannii were used to determine the activity of the following antimicrobial combinations by CB method and E-test: Col+cefoperazone/sulbactam (Cps), Cps+moxifloxacin (Mox), and Col+Mox. Comparison of CB and E-t...
In recent years, Acinetobacter strains have emerged as one of the most important nosocomial pathogen...
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning because of...
The purpose of this investigation was to compare the efficacy of colistin-based therapies in extreme...
Objective: Acinetobacter baumannii species cause nosocomial infections and can subsequently develop ...
Carbapenem-resistant Acinetobacter baumannii (CR-Ab) infections are associated with high morbidity a...
Objective: Acinetobacter baumannii species cause nosocomial infections and can subsequently develop...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Background: This study was designed to verify the effectiveness of antimicrobial combination therapy...
Raziyeh Kheshti,1 Bahman Pourabbas,2 Maryam Mosayebi,3 Afsaneh Vazin1 1Department of Clinical Pharm...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
ABSTRACT: The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is increas...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
In recent years, Acinetobacter strains have emerged as one of the most important nosocomial pathogen...
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning because of...
The purpose of this investigation was to compare the efficacy of colistin-based therapies in extreme...
Objective: Acinetobacter baumannii species cause nosocomial infections and can subsequently develop ...
Carbapenem-resistant Acinetobacter baumannii (CR-Ab) infections are associated with high morbidity a...
Objective: Acinetobacter baumannii species cause nosocomial infections and can subsequently develop...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Introduction: Antibiotic resistance is an important issue that may worsen the clinical evolution of ...
Background: This study was designed to verify the effectiveness of antimicrobial combination therapy...
Raziyeh Kheshti,1 Bahman Pourabbas,2 Maryam Mosayebi,3 Afsaneh Vazin1 1Department of Clinical Pharm...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
ABSTRACT: The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is increas...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
Acinetobacter baumannii has emerged as one of the most important nosocomial patho- gens and mul...
In recent years, Acinetobacter strains have emerged as one of the most important nosocomial pathogen...
Emerging resistance to colistin in Acinetobacter baumannii clinical strains is concerning because of...
The purpose of this investigation was to compare the efficacy of colistin-based therapies in extreme...